Investors Asset Management of Georgia Inc. GA ADV Has $445,000 Holdings in CVS Health Co. (NYSE:CVS)

Investors Asset Management of Georgia Inc. GA ADV reduced its position in CVS Health Co. (NYSE:CVS) by 7.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 9,905 shares of the pharmacy operator’s stock after selling 816 shares during the quarter. Investors Asset Management of Georgia Inc. GA ADV’s holdings in CVS Health were worth $445,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Cromwell Holdings LLC acquired a new position in shares of CVS Health in the 4th quarter worth approximately $117,000. Handelsbanken Fonder AB grew its position in CVS Health by 3.6% in the fourth quarter. Handelsbanken Fonder AB now owns 603,225 shares of the pharmacy operator’s stock valued at $27,079,000 after acquiring an additional 20,955 shares during the period. Corps Capital Advisors LLC acquired a new position in CVS Health during the fourth quarter worth $239,000. Financial Perspectives Inc boosted its stake in shares of CVS Health by 137.5% in the 4th quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator’s stock valued at $36,000 after purchasing an additional 466 shares in the last quarter. Finally, Bank of Jackson Hole Trust bought a new stake in shares of CVS Health in the 4th quarter worth about $153,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have commented on CVS. Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price target on the stock in a research report on Tuesday, December 3rd. Cantor Fitzgerald upgraded CVS Health from a “neutral” rating to an “overweight” rating in a research report on Wednesday, February 12th. Evercore ISI lifted their price objective on CVS Health from $60.00 to $65.00 and gave the company an “outperform” rating in a research report on Monday, January 27th. UBS Group decreased their target price on CVS Health from $62.00 to $59.00 and set a “neutral” rating on the stock in a report on Tuesday, February 11th. Finally, Truist Financial lifted their price target on CVS Health from $60.00 to $76.00 and gave the company a “buy” rating in a report on Thursday, February 13th. Four equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and an average price target of $70.00.

CVS Health Stock Performance

Shares of CVS stock opened at $65.20 on Friday. The stock has a 50-day moving average of $52.11 and a 200-day moving average of $56.18. CVS Health Co. has a one year low of $43.56 and a one year high of $80.75. The stock has a market cap of $82.21 billion, a PE ratio of 17.81, a price-to-earnings-growth ratio of 0.99 and a beta of 0.61. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. As a group, sell-side analysts expect that CVS Health Co. will post 5.9 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.08%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s payout ratio is currently 72.68%.

Insider Transactions at CVS Health

In related news, Director Michael F. Mahoney bought 30,000 shares of CVS Health stock in a transaction that occurred on Tuesday, February 18th. The stock was purchased at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the purchase, the director now owns 39,356 shares in the company, valued at approximately $2,625,045.20. This trade represents a 320.65 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.24% of the stock is owned by insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.